Shane Campbell's most recent trade in West Pharmaceutical Services, Inc. was a trade of 473 Rst. Stock Unit done . Disclosure was reported to the exchange on May 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2026 | 473 | 1,417 | - | - | Rst. Stock Unit | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2026 | 473 | 747 (0%) | 0% | - | Common Stock | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2026 | 296 | 358 (0%) | 0% | - | Common Stock | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2026 | 296 | 886 | - | - | Rst. Stock Unit | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 314.23 per share. | 12 May 2026 | 134 | 612 (0%) | 0% | 314.2 | 42,107 | Common Stock |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 313.30 per share. | 12 May 2026 | 84 | 274 (0%) | 0% | 313.3 | 26,317 | Common Stock |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 2,691 | 2,691 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 1,131 | 1,131 | - | - | Rst. Stock Unit | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,852 | 2,852 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 1,891 | 1,891 | - | - | Rst. Stock Unit | |
| West Pharma Services | Shane Campbell | SVP, Proprietary Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 1,182 | 1,182 | - | - | Rst. Stock Unit |